FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS

摘要

The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R¹, R², R³, R⁴, R⁵, A¹, A², A³, A⁴, and A⁵, are as defined herein. The compounds of formula I or II have ALK and/or c-Met inhibitory activity, and may be used to treat proliferative disorders.